Healthcare trends

Market Research Future (MRFR) has published a report about the global  multiple Sclerosis Treatment Market Size  that predicts a raise for this market with 3.5% CAGR (Compound Annual Growth Rate) between 2017 and 2023. Multiple Sclerosis Treatment Market to Witness a Thriving Growth by 2023 Leading Manufacturers Bayer Healthcare (Germany), Teva Pharmaceuticals (Israel), Biogen Idec (US), Sanofi Aventis (France), Pfizer Inc. (US), Merck (US), AbbVie (US), and Novartis (Switzerland)among others. Market Overview The globalMultiple Sclerosis Treatment Market Size   is accruing rapidly mainly due to the increasing prevalence of the disease. Although MS is largely associated with both genetic and environmental risk factors, other risk factors involved in the development of MS include obesity and smoking high altitude, female gender, deficiency of vitamin D, and Epstein Barr virus infection. Segmental Analysis The global multiple sclerosis treatment mar...

Market Research Future has published a half-cooked research report on the Multiple Sclerosis Treatment Market Research Report - Global Forecast till 2023. Market is estimated to demonstrate 3.5% CAGR throughout the forecast period (2017-2023) Top Manufacturers Leading players in the global multiple sclerosis treatment market include AbbVie, Novartis, Merck, Sanofi Aventis, Pfizer Inc., Biogen Idec, Bayer Healthcare, and Teva Pharmaceuticals. Multiple Sclerosis Treatment Market Overview Market Research Future postulates that the global multiple sclerosis treatment market is estimated to demonstrate 3.5% CAGR throughout the forecast period (2017-2023). Factors such as increasing patient pool and screening for better treatment options are likely to favor the market growth worldwide. Multiple sclerosis is referred to as an inflammatory, chronic, and an autoimmune disease which generally affects the central nervous system. It e specially affects the communication between...